ESMO Congress is described as a global oncology platform. The 2025 conference brought together healthcare professionals from around the world. It gave everyone an opportunity to learn from leading experts; with some clinical and technical talks, and other talks more general and of interest to everyone. If you didn't get the chance to attend - one of our team members (below), gives you a flavour of what the experience was like.
"Attending this year’s ESMO Congress in Berlin was nothing short of breathtaking. The sheer scale hit me from the start: a grand venue at Messe Berlin hosting around 34,000 oncology professionals, clinicians, scientists, industry partners, patient-advocates converging from every corner of the globe.
"Walking the halls, stepping into one of the many simultaneous sessions, I sensed the full weight of what this gathering means: an entire ecosystem of cancer research, translational science, diagnostics, treatment innovations, all in motion together. Lectures, poster sessions, industry showcases, and networking moments: everything underpinned by the unifying language of English, which somehow still feels remarkable in an event of this global magnitude.
"What struck me most was how the breadth of topics mirrored the complexity of cancer itself. From tumour-agnostic treatment modalities to advanced imaging, AI applied to oncology, radioligand therapeutics scaling up, early detection strategies, and de-escalation of therapy where appropriate — the agenda spanned the full spectrum of what “understanding cancer” means today.
"For someone engaged in genomics, early detection, and service design, it was inspiring to see how these themes connect: the molecular biology of cancer increasingly feeds into diagnostics, which in turn shape precision treatment decisions, which feed back into how we structure services and pathways. And it isn’t just about new drugs. It’s about implementing that science into real-world care, making it accessible, equitable, streamlined.
"In short: ESMO 2025 didn’t just showcase what’s new. It showed us where cancer care is going and how each of us, in our roles, has a place in that forward movement."
.
